NASDAQ:MGEN - Miragen Therapeutics SEC Filings & 10K Form

$2.25
-0.08 (-3.43 %)
(As of 07/19/2019 04:00 PM ET)
Today's Range
$2.23
Now: $2.25
$2.35
50-Day Range
$2.05
MA: $2.28
$2.49
52-Week Range
$2.01
Now: $2.25
$7.07
Volume81,200 shs
Average Volume236,115 shs
Market Capitalization$69.59 million
P/E RatioN/A
Dividend YieldN/A
Beta1.15

SEC Filings

Miragen Therapeutics (NASDAQ:MGEN) SEC Filings

DateFilerForm TypeView
07/19/2019
7:01 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/21/2019
4:18 PM
Miragen Therapeutics (Issuer)
TURNER JOSEPH L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2019
4:17 PM
Miragen Therapeutics (Issuer)
Morris Arlene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2019
4:16 PM
KOCH KEVIN (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2019
4:15 PM
Hughes Thomas E. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2019
4:14 PM
Hatfield Jeffrey S. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2019
4:12 PM
Bowden Christopher (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/21/2019
6:15 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/08/2019
3:01 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/03/2019
3:46 PM
Miragen Therapeutics (Filer)
Form DEFA14A
View Filing
05/03/2019
3:35 PM
Miragen Therapeutics (Filer)
Form DEF 14A
View Filing
04/29/2019
6:16 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/26/2019
6:15 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/05/2019
4:24 PM
Hughes Thomas E. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2019
3:16 PM
Miragen Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
03/14/2019
9:45 AM
Miragen Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/13/2019
3:02 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/08/2019
3:34 PM
Miragen Therapeutics (Issuer)
RUBIN PAUL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
3:32 PM
Levy Adam Scott (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/08/2019
3:25 PM
Marshall William Stuart (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/24/2019
3:08 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/10/2019
6:21 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/03/2019
3:06 PM
683 Capital Partners, LP (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G
View Filing
12/20/2018
6:15 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/06/2018
6:15 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/03/2018
6:16 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/19/2018
12:25 PM
Miragen Therapeutics (Filer)
Form CT ORDER
View Filing
11/13/2018
9:38 AM
FMR LLC (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G/A
View Filing
11/07/2018
4:17 PM
Miragen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/07/2018
3:02 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/12/2018
3:38 PM
Hughes Thomas E. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/30/2018
11:00 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/22/2018
4:51 PM
Levy Adam Scott (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/22/2018
4:48 PM
Leverone Jason A. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/22/2018
4:44 PM
Marshall William Stuart (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/20/2018
9:30 AM
Miragen Therapeutics (Filer)
Form CT ORDER
View Filing
08/09/2018
3:18 PM
Leverone Jason A. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/07/2018
3:06 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/06/2018
3:34 PM
Miragen Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
View Filing
08/06/2018
3:16 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/10/2018
6:15 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/28/2018
3:49 PM
Miragen Therapeutics (Issuer)
TURNER JOSEPH L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/28/2018
3:46 PM
Miragen Therapeutics (Issuer)
Morris Arlene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/28/2018
3:44 PM
KOCH KEVIN (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/28/2018
3:41 PM
Hughes Thomas E. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/28/2018
3:38 PM
Hatfield Jeffrey S. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/28/2018
3:35 PM
Bowden Christopher (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/28/2018
3:31 PM
Booth Bruce (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/28/2018
3:17 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/04/2018
6:42 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/22/2018
11:46 AM
Miragen Therapeutics (Filer)
Form CT ORDER
View Filing
05/09/2018
4:20 PM
Miragen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/09/2018
3:15 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/08/2018
3:18 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/02/2018
3:18 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/27/2018
6:13 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/20/2018
4:04 PM
Miragen Therapeutics (Filer)
Form 10-K/A
View Filing
04/06/2018
5:30 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/27/2018
7:31 AM
Miragen Therapeutics (Filer)
Form 8-K/A
View Filing
03/27/2018
6:17 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/15/2018
5:06 AM
Miragen Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
02/28/2018
3:16 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/22/2018
6:11 PM
Levy Adam Scott (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/22/2018
6:09 PM
Leverone Jason A. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/22/2018
6:06 PM
Marshall William Stuart (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/15/2018
3:36 PM
Marshall William Stuart (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/13/2018
3:59 PM
Booth Bruce (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/09/2018
3:06 PM
Miragen Therapeutics (Filer)
Form 424B5
View Filing
02/05/2018
5:20 AM
Miragen Therapeutics (Filer)
Form 424B5
View Filing
02/05/2018
5:16 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/02/2018
7:20 PM
Leverone Jason A. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/02/2018
7:17 PM
Levy Adam Scott (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/02/2018
7:15 PM
Miragen Therapeutics (Issuer)
RUBIN PAUL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/02/2018
7:11 PM
Marshall William Stuart (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/30/2018
7:00 AM
JAFCO SV4 Investment Limited Partnership (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G/A
View Filing
01/05/2018
3:24 PM
Hughes Thomas E. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/05/2018
3:22 PM
Booth Bruce (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/05/2018
3:17 PM
Miragen Therapeutics (Issuer)
Morris Arlene (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
01/05/2018
3:11 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/22/2017
5:08 PM
Hughes Thomas E. (Reporting)
Miragen Therapeutics (Issuer)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/11/2017
3:55 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 7/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel